- P-ISSN 1010-0695
- E-ISSN 2288-3339
Objectives: The main goals of cancer treatment are improvement of quality of life and survival prolongation. There is a limitation to prolonging the survival time in hepatobiliary and pancreatic cancer. The purpose of this study was to evaluate the quality of life of hepatobiliary and pancreatic cancer patients who visited for traditional Korean cancer treatment. Methods: We evaluated the quality of life of 23 hepatobiliary and pancreatic cancer patients who visited for oriental medicine treatment at East-West Neo Medical Center from June to October of 2007. FACT-G (Functional Assessment Cancer Therapy-General), used in this study, is a scale for evaluation of QOL confirmed validity and reliability, popularly used in many countries to evaluate QOL of cancer patients. Results: The average age of enrolled patients was 57. There were 10 hepatocellular carcinoma patients, 7 pancreatic cancer patients, 6 biliary tract cancer patients. Twenty one patients were in stage Ⅳ and 20 patients had distant metastases. By Sasang constitution, Taeumin were 7, Soyangin were 8, and Soeumuin were 8. The baselines of FACT-G score in the first visit were from 34.33 to 85, and the mean score was 67.3. The mean score of FACT-G in hepatocellular carcinoma patients was 67.5, that of pancreatic cancer patients was 62.5, and that of biliary tract cancer patients was 71. Conclusions: This study is valuable as an initial QOL study of hepatobiliary and pancreatic cancer patients who visited an oriental medical clinic. We believe that consistent studies will be necessary to demonstrate oriental treatment-related quality of life with hepatobiliary and pancreatic cancer.
1. 통계청. 2005년 사망원인 통계연보. 2005년
2. Katsumasa Kuroi, Kojiro Shimozuma, Shozo Ohsumi, Hirohisa Imai, Michikazu Ono. Current status of health outcome assessment of medical treatment in breast cancer. breast cancer. 2007; 14(1):74-80
3. J. L. Steel, D. T. Eton, D. Cella, M. C. Olek, B. I. Carr. Clinically meaningful changes in health-related quality of life in patients diagnosed with hepatobiliary carcinoma. Annals of Oncology. 2006;17(2):304-312.
4. 김호영, 이종인, 심광용, 윤상진, 박종구, 방대건, 최서영, 이창훈. 진행성 위암 및 간암에서 양한방 협진의 치료효과. 건국의과학학술지. 2004;13(2) :115-127
5. 장우익, 이광훈, 심영학, 권상옥, 홍인수, 이흥재, 전근재, 임채선, 김남동. 치료받지 않은 간암환자의 평균 생존기간 및 예후인자에 대한 고찰. 대한소화기병학회지. 1987;19(2):172-188(620)
6. 김창민, 박태성, 김봉석, 이정애, 도영수, 이진오, 임덕, 강태웅, 강윤구. 간세포암에 대한 경간동맥화학색전요법: Adriamycin 단독, Cisplatin단독 및 Adriamycin 과 Cisplatin 복합투여의 비교연구. 대한암학회지. 1998;30(6):1156-1167
7. 김호영, 김민수, 이동기, 이종인, 권상옥, 심광용, 심영학, 백순구, 장우익, 김용태, 김재권. 진행성 간세포암에서 지속적 경구 Etoposide와 Tamo- xifen의 치료효과. 대한간암학회지. 2000;6(1):41 -51
8. Khan S, Taylor-Robinson S, Toledano M, Beck A, Elliott P, Thomas H. Changing international trends in mortality rates for liver, biliary, pancr- eatic tumors. Hepatology. 2002;37(6):806-813
9. Shaib Y, El-Serag H. The epidemiology of cholangiocarcinoma. Semin Liver Dis. 2004;24 (2):115-125
10. 안수열, 임학, 문미경, 최영식, 차태준, 서승연, 구자영, 박병채. 담도암에 대한 임상적 고찰. 대한내과학회지. 1992;42(2):148-154
11. Glimelius B, Hoffman K, Sjoden PO, Jacobsson G, Sellstrom H, Enander LK, Linne T, Svensson C. Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol 1996;7(6):593-600
12. 이상주, 이용찬, 송시영, 정재복, 강진경, 박인서. 췌장암의 임상적 고찰. 대한소화기병학회지. 1994 ;26(6):1010-1020
13. 송시영. 췌장암. 대한의사협회지. 2003;8월호: 729-740
14. Johnson JR, Temple R. Food and Drug Admin- istration requirement for approval of new antica- ncer drugs. Cancer Treat Rep. 1985;69: 1155-1157
15. 김환, 유희정, 김유진, 한오수, 이규형, 이제환, 서철원, 김우건, 김진천, 안세현. Functional Assess- ment Cancer Therapy-General (FACT-G)의 한국판 개발 및 타당화. 한국심리학회지:임상. 2003; 22(1):215-229
16. 조정효, 손창규, 이연월, 유화승, 성정현, 김소영, 이명민, 강위창, 조종관. 암관련 삶의 질 평가 도구에 관한 연구 현황. 대한한방내과학회지. 2006; 27(1):84-91
17. 이남헌, 조정효, 손창규, 유화승, 이연월, 윤담희, 이종훈, 방선휘, 조종관. 암의 종류 및 증상에 따른 삶의 질 평가 청도에 관한 연구 현황 분석. 대한한방내과학회지. 2006;27(3):555-560